GlassScriptPhysician profile
Akshit Sharma
NPI 1205256518
$12,826.41
in general payments reported to CMS, 2019-2025
32 companies · $2,223 in 2025
The $2,223 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,185 · 2020: $1,340 · 2021: $353 · 2022: $736 · 2023: $725 · 2024: $6,265 · 2025: $2,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $5,458 · Food and Beverage: $2,683 · Travel and Lodging: $1,072.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $5,458.33 |
| Food and Beverage | $2,682.71 |
| Travel and Lodging | $1,071.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $6,039.24 | 2023-2024 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Alphavac |
| Boston Scientific Corporation | $2,184.78 | 2019-2025 | General - Balloon Catheters |
| Penumbra, INC. | $1,657.88 | 2025 | Indigo System |
| Shockwave Medical, INC | $368.51 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $346.54 | 2022-2024 | (Br5) Peripheral Ivus |
| Abbott Laboratories | $277.28 | 2019-2023 | Cardiomems |
| Medtronic Vascular, INC. | $262.04 | 2019-2020 | |
| Pfizer INC. | $256.89 | 2021-2024 | |
| Medtronic, INC. | $198.82 | 2023-2025 | Symplicity G3, Venaseal |
| Biotronik INC. | $183.65 | 2021-2025 | Orsiro Mission |
| Abiomed | $129.32 | 2022-2024 | Impella |
| Bard Peripheral Vascular, INC. | $124.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $108.70 | 2019 | |
| Novartis Pharmaceuticals Corporation | $91.48 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $70.31 | 2022-2023 | Verquvo |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $66.53 | 2022-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $53.93 | 2022-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.52 | 2021-2024 | Lifevest |
| Becton, Dickinson and Company | $50.39 | 2023 | Venclose Maven Catheter |
| Cardiva Medical, INC. | $44.19 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $43.98 | 2022-2024 | Camzyos, Eliquis |
| Novo Nordisk INC | $33.89 | 2023 | Ozempic, Rybelsus |
| Lilly USA, LLC | $25.33 | 2020 | |
| Edwards Lifesciences Corporation | $23.43 | 2021 | |
| Itamar Medical INC | $22.35 | 2023 | Watchpatone |
| Actelion Pharmaceuticals US, INC. | $17.39 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.85 | 2021 | |
| Inari Medical, INC. | $16.68 | 2022 | |
| Kestra Medical Technology Services, INC. | $16.04 | 2024 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $15.27 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.60 | 2022 | |
| Esperion Therapeutics, INC. | $13.10 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akshit Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.